XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Playback speed
10 seconds
Debates in CLL: The Case for BTKi Monotherapy in 1L
70 views
February 16, 2024
Chapters
Comparing Monotherapy & Combinations in CLL
00:00
Progression-Free Survival in CLL Treatment Trials
05:27
Monotherapy Outcomes in CLL with TP53 Mutations
08:58
Considering BTK Inhibitor Toxicities in Treatment Choice
10:23
Comments 0
Login to view comments.
Click here to Login
Leukemia